Shares of FIGS, Inc. (FIGS) tumbled 10.10% in after-hours trading on Thursday following the release of the company's first-quarter 2025 financial results and updated full-year outlook. The global healthcare apparel brand faced headwinds due to changes in U.S. trade policies, prompting a revision of its 2025 projections.
While FIGS reported a 4.7% year-over-year increase in net revenues to $124.9 million for Q1 2025, exceeding expectations, the company's bottom line showed signs of pressure. Net income turned to a slight loss of $(0.1) million, compared to a profit of $1.4 million in the same period last year. The adjusted EBITDA margin also declined to 7.2% from 10.9% in the previous year.
The most significant factor driving the stock's after-hours plunge was FIGS' updated 2025 outlook. Chief Financial Officer Sarah Oughtred stated, "While 2025 started on a strong note, changes in U.S. trade policies have added greater variability to our planning, particularly in the second half of the year." As a result, FIGS now expects full-year 2025 net revenue growth to be down in the low-single-digits compared to 2024, with an adjusted EBITDA margin between 7.5% and 8.5%. This cautious outlook reflects the projected impact of the current tariff structure, excluding the currently-paused reciprocal tariffs, and has clearly unsettled investors.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.